Zebrafish models of Tauopathy

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 3, 2011, Pages 353-363

  Bai, Qing ^a   Burton, Edward A ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Neurodegeneration; Progressive supranuclear palsy; Tau; Tauopathy; Transgenic; Zebrafish

Indexed keywords

TAU PROTEIN;

BIOCHEMISTRY; BRAIN; CELL DEATH; CELL POPULATION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CHROMOSOME 17; DEMENTIA; DENDRITIC CELL; GENE EXPRESSION; NERVE CELL; NONHUMAN; PARKINSONISM; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TAUOPATHY; TRANSGENE; ZEBRA FISH;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; TAUOPATHIES; ZEBRAFISH;

DANIO RERIO; MURINAE;

EID: 78751704164     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.09.004     Document Type: Review

References (127)

1. Weingarten M.D., Lockwood A.H., Hwo S.Y., Kirschner M.W. A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. U. S. A. 1975, 72:1858-1862.
2. Witman G.B., Cleveland D.W., Weingarten M.D., Kirschner M.W. Tubulin requires tau for growth onto microtubule initiating sites. Proc. Natl. Acad. Sci. U. S. A. 1976, 73:4070-4074.
3. Binder L.I., Frankfurter A., Rebhun L.I. The distribution of tau in the mammalian central nervous system. J. Cell Biol. 1985, 101:1371-1378.
4. Butner K.A., Kirschner M.W. Tau protein binds to microtubules through a flexible array of distributed weak sites. J. Cell Biol. 1991, 115:717-730.
5. Gustke N., Trinczek B., Biernat J., Mandelkow E.M., Mandelkow E. Domains of tau protein and interactions with microtubules. Biochemistry 1994, 33:9511-9522.
6. Goedert M., Spillantini M.G., Potier M.C., Ulrich J., Crowther R.A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 1989, 8:393-399.
7. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:4051-4055.
8. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989, 3:519-526.
9. Goedert M., Spillantini M.G., Crowther R.A. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1983-1987.
10. Drechsel D.N., Hyman A.A., Cobb M.H., Kirschner M.W. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell 1992, 3:1141-1154.
11. Goedert M., Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 1990, 9:4225-4230.
12. Panda D., Samuel J.C., Massie M., Feinstein S.C., Wilson L. Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9548-9553.
13. Goode B.L., Feinstein S.C. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau. J. Cell Biol. 1994, 124:769-782.
14. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Heutink P., et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
15. Dixit R., Ross J.L., Goldman Y.E., Holzbaur E.L. Differential regulation of dynein and kinesin motor proteins by tau. Science 2008, 319:1086-1089.
16. Matsuo E.S., Shin R.W., Billingsley M.L., Van deVoorde A., O'Connor M., Trojanowski J.Q., Lee V.M. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994, 13:989-1002.
17. Liu F., Iqbal K., Grundke-Iqbal I., Hart G.W., Gong C.X. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10804-10809.
18. Lee G., Thangavel R., Sharma V.M., Litersky J.M., Bhaskar K., Fang S.M., Do L.H., Andreadis A., Van Hoesen G., Ksiezak-Reding H. Phosphorylation of tau by fyn: implications for Alzheimer's disease. J. Neurosci. 2004, 24:2304-2312.
19. Dorval V., Fraser P.E. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J. Biol. Chem. 2006, 281:9919-9924.
20. Horiguchi T., Uryu K., Giasson B.I., Ischiropoulos H., LightFoot R., Bellmann C., Richter-Landsberg C., Lee V.M., Trojanowski J.Q. Nitration of tau protein is linked to neurodegeneration in tauopathies. Am. J. Pathol. 2003, 163:1021-1031.
21. Hasegawa M., Morishima-Kawashima M., Takio K., Suzuki M., Titani K., Ihara Y. Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. J. Biol. Chem. 1992, 267:17047-17054.
22. Hanger D.P., Anderton B.H., Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 2009, 15:112-119.
23. Biernat J., Gustke N., Drewes G., Mandelkow E.M., Mandelkow E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 1993, 11:153-163.
24. Gustke N., Steiner B., Mandelkow E.M., Biernat J., Meyer H.E., Goedert M., Mandelkow E. The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Lett. 1992, 307:199-205.
25. Lu P.J., Wulf G., Zhou X.Z., Davies P., Lu K.P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 1999, 399:784-788.
26. Reynolds C.H., Garwood C.J., Wray S., Price C., Kellie S., Perera T., Zvelebil M., Yang A., Sheppard P.W., Varndell I.M., Hanger D.P., Anderton B.H. Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases. J. Biol. Chem. 2008, 283:18177-18186.
27. Kenessey A., Yen S.H. The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments. Brain Res. 1993, 629:40-46.
28. Brion J.P., Smith C., Couck A.M., Gallo J.M., Anderton B.H. Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J. Neurochem. 1993, 61:2071-2080.
29. Hong M., Chen D.C., Klein P.S., Lee V.M. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 1997, 272:25326-25332.
30. Hong M., Lee V.M. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem. 1997, 272:19547-19553.
31. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., LaFrancois J., Feinstein B., Burns M., Krishnamurthy P., Wen Y., Bhat R., Lewis J., Dickson D., Duff K. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6990-6995.
32. Caccamo A., Oddo S., Tran L.X., LaFerla F.M. Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am. J. Pathol. 2007, 170:1669-1675.
33. Terwel D., Muyllaert D., Dewachter I., Borghgraef P., Croes S., Devijver H., Van Leuven F. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am. J. Pathol. 2008, 172:786-798.
34. Noble W., Olm V., Takata K., Casey E., Mary O., Meyerson J., Gaynor K., LaFrancois J., Wang L., Kondo T., Davies P., Burns M., Veeranna, Nixon R., Dickson D., Matsuoka Y., Ahlijanian M., Lau L.F., Duff K. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 2003, 38:555-565.
35. Cruz J.C., Tseng H.C., Goldman J.A., Shih H., Tsai L.H. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 2003, 40:471-483.
36. Sobue K., Agarwal-Mawal A., Li W., Sun W., Miura Y., Paudel H.K. Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau. J. Biol. Chem. 2000, 275:16673-16680.
37. Li T., Hawkes C., Qureshi H.Y., Kar S., Paudel H.K. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta. Biochemistry 2006, 45:3134-3145.
38. Sengupta A., Wu Q., Grundke-Iqbal I., Iqbal K., Singh T.J. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. Mol. Cell. Biochem. 1997, 167:99-105.
39. Goedert M., Jakes R., Qi Z., Wang J.H., Cohen P. Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J. Neurochem. 1995, 65:2804-2807.
40. Sontag E., Nunbhakdi-Craig V., Bloom G.S., Mumby M.C. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J. Cell Biol. 1995, 128:1131-1144.
41. Goedert M., Spillantini M.G., Cairns N.J., Crowther R.A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 1992, 8:159-168.
42. Sergeant N., David J.P., Lefranc D., Vermersch P., Wattez A., Delacourte A. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases. FEBS Lett. 1997, 412:578-582.
43. Arai T., Ikeda K., Akiyama H., Shikamoto Y., Tsuchiya K., Yagishita S., Beach T., Rogers J., Schwab C., McGeer P.L. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol. (Berl.) 2001, 101:167-173.
44. Sergeant N., Wattez A., Delacourte A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. J. Neurochem. 1999, 72:1243-1249.
45. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 1999, 8:711-715.
46. Caffrey T.M., Joachim C., Paracchini S., Esiri M.M., Wade-Martins R. Haplotype-specific expression of exon 10 at the human MAPT locus. Hum. Mol. Genet. 2006, 15:3529-3537.
47. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7737-7741.
48. van Swieten J., Spillantini M.G. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol. 2007, 17:63-73.
49. Hong M., Zhukareva V., Vogelsberg-Ragaglia V., Wszolek Z., Reed L., Miller B.I., Geschwind D.H., Bird T.D., McKeel D., Goate A., Morris J.C., Wilhelmsen K.C., Schellenberg G.D., Trojanowski J.Q., Lee V.M. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998, 282:1914-1917.
50. Lee V.M., Kenyon T.K., Trojanowski J.Q. Transgenic animal models of tauopathies. Biochim. Biophys. Acta 2005, 1739:251-259.
51. Denk F., Wade-Martins R. Knock-out and transgenic mouse models of tauopathies. Neurobiol. Aging 2009, 30:1-13.
52. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53:337-351.
53. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., Forster C., Yue M., Orne J., Janus C., Mariash A., Kuskowski M., Hyman B., Hutton M., Ashe K.H. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309:476-481.
54. Spires T.L., Orne J.D., SantaCruz K., Pitstick R., Carlson G.A., Ashe K.H., Hyman B.T. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am. J. Pathol. 2006, 168:1598-1607.
55. Oddo S., Vasilevko V., Caccamo A., Kitazawa M., Cribbs D.H., LaFerla F.M. Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J. Biol. Chem. 2006, 281:39413-39423.
56. Gotz J., Chen F., van Dorpe J., Nitsch R.M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001, 293:1491-1495.
57. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G., Yen S.H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M., McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001, 293:1487-1491.
58. Brunden K.R., Trojanowski J.Q., Lee V.M. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat. Rev. Drug Discov. 2009, 8:783-793.
59. Le Corre S., Klafki H.W., Plesnila N., Hubinger G., Obermeier A., Sahagun H., Monse B., Seneci P., Lewis J., Eriksen J., Zehr C., Yue M., McGowan E., Dickson D.W., Hutton M., Roder H.M. An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:9673-9678.
60. Zhang B., Maiti A., Shively S., Lakhani F., McDonald-Jones G., Bruce J., Lee E.B., Xie S.X., Joyce S., Li C., Toleikis P.M., Lee V.M., Trojanowski J.Q. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:227-231.
61. Dickey C.A., Kamal A., Lundgren K., Klosak N., Bailey R.M., Dunmore J., Ash P., Shoraka S., Zlatkovic J., Eckman C.B., Patterson C., Dickson D.W., Nahman N.S., Hutton M., Burrows F., Petrucelli L. The high-affinity HSP90 - CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J. Clin. Invest. 2007, 117:648-658.
62. Kawakami K. Transgenesis and gene trap methods in zebrafish by using the Tol2 transposable element. Methods Cell Biol. 2004, 77:201-222.
63. Soroldoni D., Hogan B.M., Oates A.C. Simple and efficient transgenesis with meganuclease constructs in zebrafish. Methods Mol. Biol. 2009, 546:117-130.
64. Nasevicius A., Ekker S.C. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 2000, 26:216-220.
65. Peters K.G., Rao P.S., Bell B.S., Kindman L.A. Green fluorescent fusion proteins: powerful tools for monitoring protein expression in live zebrafish embryos. Dev. Biol. 1995, 171:252-257.
66. McLean D.L., Fetcho J.R. Using imaging and genetics in zebrafish to study developing spinal circuits in vivo. Dev. Neurobiol. 2008, 68:817-834.
67. Wen L., Wei W., Gu W., Huang P., Ren X., Zhang Z., Zhu Z., Lin S., Zhang B. Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish. Dev. Biol. 2008, 314:84-92.
68. Peri F., Nusslein-Volhard C. Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell 2008, 133:916-927.
69. Driever W., Solnica-Krezel L., Schier A.F., Neuhauss S.C., Malicki J., Stemple D.L., Stainier D.Y., Zwartkruis F., Abdelilah S., Rangini Z., Belak J., Boggs C. A genetic screen for mutations affecting embryogenesis in zebrafish. Development 1996, 123:37-46.
70. Solnica-Krezel L., Schier A.F., Driever W. Efficient recovery of ENU-induced mutations from the zebrafish germline. Genetics 1994, 136:1401-1420.
71. Golling G., Amsterdam A., Sun Z., Antonelli M., Maldonado E., Chen W., Burgess S., Haldi M., Artzt K., Farrington S., Lin S.Y., Nissen R.M., Hopkins N. Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development. Nat. Genet. 2002, 31:135-140.
72. Amsterdam A., Burgess S., Golling G., Chen W., Sun Z., Townsend K., Farrington S., Haldi M., Hopkins N. A large-scale insertional mutagenesis screen in zebrafish. Genes Dev. 1999, 13:2713-2724.
73. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 2005, 4:35-44.
74. Stern H.M., Murphey R.D., Shepard J.L., Amatruda J.F., Straub C.T., Pfaff K.L., Weber G., Tallarico J.A., King R.W., Zon L.I. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat. Chem. Biol. 2005, 1:366-370.
75. Molina G., Vogt A., Bakan A., Dai W., Queiroz de Oliveira P., Znosko W., Smithgall T.E., Bahar I., Lazo J.S., Day B.W., Tsang M. Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages. Nat. Chem. Biol. 2009, 5:680-687.
76. Rihel J., Prober D.A., Arvanites A., Lam K., Zimmerman S., Jang S., Haggarty S.J., Kokel D., Rubin L.L., Peterson R.T., Schier A.F. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010, 327:348-351.
77. Wullimann M.F., Rupp B., Reichert H. Neuroanatomy of the Zebrafish Brain 1996, Birkhauser-Verlag, Berlin.
78. Mueller T., Wullimann M.F. An evolutionary interpretation of teleostean forebrain anatomy. Brain Behav. Evol. 2009, 74:30-42.
79. Rink E., Wullimann M.F. Connections of the ventral telencephalon (subpallium) in the zebrafish (Danio rerio). Brain Res. 2004, 1011:206-220.
80. Mueller T., Vernier P., Wullimann M.F. The adult central nervous cholinergic system of a neurogenetic model animal, the zebrafish Danio rerio. Brain Res. 2004, 1011:156-169.
81. Sallinen V., Torkko V., Sundvik M., Reenilä I., Khrustalyov D., Kaslin J., Panula P. MPTP and MPP+ target specific aminergic cell populations in larval zebrafish. J. Neurochem. 2008, 108(3):719-731.
82. Bernardos R.L., Raymond P.A. GFAP transgenic zebrafish. Gene Expr. Patterns 2006, 6:1007-1013.
83. Tomizawa K., Inoue Y., Nakayasu H. A monoclonal antibody stains radial glia in the adult zebrafish (Danio rerio) CNS. J. Neurocytol. 2000, 29:119-128.
84. Kirby B.B., Takada N., Latimer A.J., Shin J., Carney T.J., Kelsh R.N., Appel B. In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development. Nat. Neurosci. 2006, 9:1506-1511.
85. Yoshida M., Macklin W.B. Oligodendrocyte development and myelination in GFP-transgenic zebrafish. J. Neurosci. Res. 2005, 81:1-8.
86. Avila R.L., Tevlin B.R., Lees J.P., Inouye H., Kirschner D.A. Myelin structure and composition in zebrafish. Neurochem. Res. 2007, 32:197-209.
87. Schweitzer J., Becker T., Schachner M., Nave K.A., Werner H. Evolution of myelin proteolipid proteins: gene duplication in teleosts and expression pattern divergence. Mol. Cell. Neurosci. 2006, 31:161-177.
88. Jeong J.Y., Kwon H.B., Ahn J.C., Kang D., Kwon S.H., Park J.A., Kim K.W. Functional and developmental analysis of the blood - brain barrier in zebrafish. Brain Res. Bull. 2008, 75:619-628.
89. Bretaud S., Allen C., Ingham P.W., Bandmann O. p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J. Neurochem. 2007, 100:1626-1635.
90. Bai Q., Mullett S.J., Garver J.A., Hinkle D.A., Burton E.A. Zebrafish DJ-1 is evolutionarily conserved and expressed in dopaminergic neurons. Brain Res. 2006, 1113:33-44.
91. Anichtchik O., Diekmann H., Fleming A., Roach A., Goldsmith P., Rubinsztein D.C. Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J. Neurosci. 2008, 28:8199-8207.
92. Sun Z., Gitler A.D. Discovery and characterization of three novel synuclein genes in zebrafish. Dev. Dyn. 2008, 237:2490-2495.
93. Flinn L., Mortiboys H., Volkmann K., Koster R.W., Ingham P.W., Bandmann O. Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain 2009, 132:1613-1623.
94. Campbell W.A., Yang H., Zetterberg H., Baulac S., Sears J.A., Liu T., Wong S.T., Zhong T.P., Xia W. Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss. J. Neurochem. 2006, 96:1423-1440.
95. Groth C., Nornes S., McCarty R., Tamme R., Lardelli M. Identification of a second presenilin gene in zebrafish with similarity to the human Alzheimer's disease gene presenilin2. Dev. Genes Evol. 2002, 212:486-490.
96. Leimer U., Lun K., Romig H., Walter J., Grunberg J., Brand M., Haass C. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. Biochemistry 1999, 38:13602-13609.
97. Chen M., Martins R.N., Lardelli M. Complex splicing and neural expression of duplicated tau genes in zebrafish embryos. J. Alzheimers Dis. 2009, 18(2):305-317.
98. Amores A., Force A., Yan Y.L., Joly L., Amemiya C., Fritz A., Ho R.K., Langeland J., Prince V., Wang Y.L., Westerfield M., Ekker M., Postlethwait J.H. Zebrafish hox clusters and vertebrate genome evolution. Science 1998, 282:1711-1714.
99. Chen Y.C., Priyadarshini M., Panula P. Complementary developmental expression of the two tyrosine hydroxylase transcripts in zebrafish. Histochem. Cell Biol. 2009, 132(4):375-381.
100. Stuart G.W., McMurray J.V., Westerfield M. Replication, integration and stable germ-line transmission of foreign sequences injected into early zebrafish embryos. Development 1988, 103:403-412.
101. Jacquier A., Dujon B. An intron-encoded protein is active in a gene conversion process that spreads an intron into a mitochondrial gene. Cell 1985, 41:383-394.
102. Thermes V., Grabher C., Ristoratore F., Bourrat F., Choulika A., Wittbrodt J., Joly J.S. I-SceI meganuclease mediates highly efficient transgenesis in fish. Mech. Dev. 2002, 118:91-98.
103. Bai Q., Wei X., Burton E.A. Expression of a 12-kb promoter element derived from the zebrafish enolase-2 gene in the zebrafish visual system. Neurosci. Lett. 2009, 449:252-257.
104. Koga A., Suzuki M., Inagaki H., Bessho Y., Hori H. Transposable element in fish. Nature 1996, 383:30.
105. Kawakami K., Shima A., Kawakami N. Identification of a functional transposase of the Tol2 element, an Ac-like element from the Japanese medaka fish, and its transposition in the zebrafish germ lineage. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11403-11408.
106. Higashijima S., Okamoto H., Ueno N., Hotta Y., Eguchi G. High-frequency generation of transgenic zebrafish which reliably express GFP in whole muscles or the whole body by using promoters of zebrafish origin. Dev. Biol. 1997, 192:289-299.
107. Long Q., Meng A., Wang H., Jessen J.R., Farrell M.J., Lin S. GATA-1 expression pattern can be recapitulated in living transgenic zebrafish using GFP reporter gene. Development 1997, 124:4105-4111.
108. Meng A., Tang H., Ong B.A., Farrell M.J., Lin S. Promoter analysis in living zebrafish embryos identifies a cis-acting motif required for neuronal expression of GATA-2. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:6267-6272.
109. Kim C.H., Ueshima E., Muraoka O., Tanaka H., Yeo S.Y., Huh T.L., Miki N. Zebrafish elav/HuC homologue as a very early neuronal marker. Neurosci. Lett. 1996, 216:109-112.
110. Park H.C., Kim C.H., Bae Y.K., Yeo S.Y., Kim S.H., Hong S.K., Shin J., Yoo K.W., Hibi M., Hirano T., Miki N., Chitnis A.B., Huh T.L. Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Dev. Biol. 2000, 227:279-293.
111. Bai Q., Garver J.A., Hukriede N.A., Burton E.A. Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene. Nucleic Acids Res. 2007, 35:6501-6516.
112. Asakawa K., Suster M.L., Mizusawa K., Nagayoshi S., Kotani T., Urasaki A., Kishimoto Y., Hibi M., Kawakami K. Genetic dissection of neural circuits by Tol2 transposon-mediated Gal4 gene and enhancer trapping in zebrafish. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1255-1260.
113. Distel M., Wullimann M.F., Koster R.W. Optimized Gal4 genetics for permanent gene expression mapping in zebrafish. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13365-13370.
114. Paquet D., Bhat R., Sydow A., Mandelkow E.M., Berg S., Hellberg S., Falting J., Distel M., Koster R.W., Schmid B., Haass C. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J. Clin. Invest. 2009, 119:1382-1395.
115. Scott E.K., Mason L., Arrenberg A.B., Ziv L., Gosse N.J., Xiao T., Chi N.C., Asakawa K., Kawakami K., Baier H. Targeting neural circuitry in zebrafish using GAL4 enhancer trapping. Nat. Methods 2007, 4:323-326.
116. Dickson D. Sporadic tauopathies: Pick's disease, corticobasal degeneration, progressive supranuclear palsy and argyrophilic grain disease. The Neuropathology of Dementia 2004, 227-256. Cambridge University Press, Cambridge. M. Esiri, V.M. Lee, J.Q. Trojanowski (Eds.).
117. Gao Y., Li P., Li L. Transgenic zebrafish that express tyrosine hydroxylase promoter in inner retinal cells. Dev. Dyn. 2005, 233:921-929.
118. Meng S., Ryu S., Zhao B., Zhang D.Q., Driever W., McMahon D.G. Targeting retinal dopaminergic neurons in tyrosine hydroxylase-driven green fluorescent protein transgenic zebrafish. Mol. Vis. 2008, 14:2475-2483.
119. Bai Q., Burton E.A. Cis-acting elements responsible for dopaminergic neuron-specific expression of zebrafish slc6a3 (dopamine transporter) in vivo are located remote from the transcriptional start site. Neuroscience 2009, 164:1138-1151.
120. Anichtchik O.V., Kaslin J., Peitsaro N., Scheinin M., Panula P. Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J. Neurochem. 2004, 88:443-453.
121. Tomasiewicz H.G., Flaherty D.B., Soria J.P., Wood J.G. Transgenic zebrafish model of neurodegeneration. J. Neurosci. Res. 2002, 70:734-745.
122. Jicha G.A., Bowser R., Kazam I.G., Davies P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 1997, 48:128-132.
123. Kidd M. Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 1963, 197:192-193.
124. Tellez-Nagel I., Wisniewski H.M. Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch. Neurol. 1973, 29:324-327.
125. Ksiezak-Reding H., Morgan K., Mattiace L.A., Davies P., Liu W.K., Yen S.H., Weidenheim K., Dickson D.W. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am. J. Pathol. 1994, 145:1496-1508.
126. Munoz-Garcia D., Ludwin S.K. Classic and generalized variants of Pick's disease: a clinicopathological, ultrastructural, and immunocytochemical comparative study. Ann. Neurol. 1984, 16:467-480.
127. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol. Acad. Sci. Hung. 1971, 19:1-8.